corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 20521

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Pines WL
The Challenge of the Internet
Drug Information Journal 1998 Jan; 32:(1):277-281
http://dij.sagepub.com/content/32/1/277.abstract


Abstract:

With the advent of the Internet just a few years ago, the Food and Drug Administration (FDA) has begun to devise a policy on how pharmaceutical and other regulated companies may use it for the purpose of product promotion. Although this policy has not been put into writing yet, there is no question that FDA has jurisdiction over product-specific materials on the Internet. It is becoming increasingly clear to FDA that the regulatory issues posed by the Internet can be resolved within the framework of current laws and regulations. The regulatory challenge of product promotion on the Internet is not the only one pharmaceutical companies face, however. Companies must find ways to create compelling web sites that not only promote products but also provide valuable disease and treatment information for health care professionals and consumers.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.